Stop using nowDrug recall · FDA · Published April 20, 2024
Revive Rx Pharmacy recalls Tirzepatide 10mg/0.5mL vial due to testosterone mix-up
Revive Rx Pharmacy recalls a compounded tirzepatide 10mg/0.5mL vial that was mislabeled with testosterone cypionate. This could cause serious harm if used incorrectly.
📍Recalling firmRevive Rx LLC dba Revive Rx Pharmacy3831 Golf Dr Ste A · Houston, TX 77018-5218
✎ GovInfoNow plain-language explainer
Revive Rx Pharmacy recalled a compounded tirzepatide 10 mg/0.5 mL vial because it was mislabeled as containing testosterone cypionate instead of tirzepatide. This mix-up could lead to serious health risks if the product is used without proper medical supervision. Read more at govinfonow.com/recall/32722-revive-rx-pharmacy-recalls-tirzepatide-10mg-0-5ml-vial-due.
“Revive Rx Pharmacy recalls Tirzepatide 10mg/0.5mL vial due to testosterone mix-up.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32722-revive-rx-pharmacy-recalls-tirzepatide-10mg-0-5ml-vial-due. Based on FDA recall #D-0511-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0511-2024%22&limit=1).
The FDA announced on April 20, 2024, that Revive Rx LLC dba Revive Rx Pharmacy is recalling Tirzepatide 10 mg/0.5 mL Sterile Solution because the product labeled as tirzepatide contains testosterone cypionate. This labeling mix-up poses a Class I hazard to consumers across the United States.
How to tell if you have it
Brand: Revive Rx Pharmacy
Product: Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial
NDC: 99000-9278-64
Lot #: 748127
Expiration: 9/24/2024
Quantity: 751 vials
The hazard
The hazard is a labeling mix-up where the product labeled as tirzepatide actually contains testosterone cypionate. The FDA classified this error as a Class I recall, indicating it is a situation where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death.
Context
GovInfoNow's records show Revive Rx LLC dba Revive Rx Pharmacy has two other recalls on record since February 11, 2022. On May 11, 2023, the company recalled a Tirzepatide 10mg/0.5mL vial due to sub-potent drug risks. On February 11, 2022, Revive Rx issued a recall for HCG Injection due to bacterial contamination identified as Paenibacillus lautus. Other recent recalls of similar products include New Life Pharma Tirzepatide Inj 15mg Vial Recall (February 26, 2026), New Life Pharma Tirzepatide 10mg Vial Recall (February 26, 2026), and ProRx recalls Tirz (October 15, 2025).
How to tell if you have this one
Check for the vial labeled 'Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial' with the internal NDC number 99000-9278-64 and lot number 748127. This product was sold by Revive Rx Pharmacy in Houston, Texas.
Brand
Revive Rx Pharmacy
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop using it now
Immediately discard the vial if you have it, as it contains testosterone cypionate instead of tirzepatide.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 46 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0511-2024 (April 20, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0511-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.